Welcome to Inventiva Pharma

No front page content has been created yet.


Latest News

FDA Approval of an Investigator Initiated IND Application to Conduct Phase II Study of Lanifibranor in Type 2 Diabetic Patients with Non-Alcoholic Fatty Liver Disease
Inventiva to Present at the 2018 JMP Securities Life Sciences Conference
Inventiva to Present at the Jefferies 2018 Global Healthcare Conference